Inhibikase Therapeutics (IKT) Shares Outstanding (Diluted) (2021 - 2026)
Inhibikase Therapeutics' Shares Outstanding (Diluted) was 174.57 million in Q2 2026, up 93.9% from 90.01 million a year earlier and up 1.3% from the prior quarter.
Powered by 
Analysis
Inhibikase Therapeutics (IKT) Shares Outstanding (Diluted) (2021 - 2026) Analysis & Trends
For FY2025, Shares Outstanding (Diluted) at Inhibikase Therapeutics came in at 98.31 million, up 314.6% from FY2024.
- Shares Outstanding (Diluted) has now increased for four consecutive years, with a four-year compound annual growth rate of 138.6% (FY2021 to FY2025).
- In earlier years, Shares Outstanding (Diluted) was 23.71 million in FY2024 (+344.6%), 5.33 million in FY2023 (+26.9%), 4.2 million in FY2022 (+38.5%) and 3.03 million in FY2021.
- The Q2 2026 figure marks the highest quarterly Shares Outstanding (Diluted) in data going back to Q2 2021.
- Compared with a year earlier, Shares Outstanding (Diluted) has increased for four straight quarters, with growth averaging 304.3% over the last six quarters.
- The year-over-year growth in Shares Outstanding (Diluted) has ranged between 0.3% (Q3 2022) and 913.8% (Q3 2025) over the last five years.
- Per Business Quant data, IKT's Shares Outstanding (Diluted) in the three quarters before Q2 2026 was 172.31 million (Q1 2026), 98.31 million (Q4 2025) and 90.05 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 893.70 Mn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 2.44 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 1.77 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 2.47 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 1.96 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 1.56 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 544.00 Mn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 1.24 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 5.70 Bn |
| 10 | Inhibikase Therapeutics | 336.92 Mn | -248.55 Mn | - | 174.57 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 174.57 Mn |
| Mar 31, 2026 | 172.31 Mn |
| Dec 31, 2025 | 98.31 Mn |
| Sep 30, 2025 | 90.05 Mn |
| Jun 30, 2025 | 90.01 Mn |
| Mar 31, 2025 | 89.54 Mn |
| Dec 31, 2024 | 23.71 Mn |
| Sep 30, 2024 | 8.88 Mn |
| Jun 30, 2024 | 7.54 Mn |
| Mar 31, 2024 | 6.34 Mn |
| Dec 31, 2023 | 5.33 Mn |
| Sep 30, 2023 | 5.34 Mn |
| Jun 30, 2023 | 5.23 Mn |
| Mar 31, 2023 | 4.59 Mn |
| Dec 31, 2022 | 4.20 Mn |
| Sep 30, 2022 | 4.20 Mn |
| Jun 30, 2022 | 4.20 Mn |
| Mar 31, 2022 | 4.20 Mn |
| Dec 31, 2021 | 3.03 Mn |
| Sep 30, 2021 | 4.19 Mn |
API Access
Inhibikase Therapeutics Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=IKT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "IKT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=IKT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();